Feline hyperthyroidism is the most common endocrine disease in older cats, and medical management with methimazole requires ongoing monitoring, pill administration stress, and careful dose adjustment.
Medical management of feline hyperthyroidism requires a long-term commitment to handling and monitoring that can itself be a source of stress for cats. Frequent pilling twice daily in a resistant cat causes fear responses, relationship breakdown with owners, and chronic low-grade stress. Transdermal gels significantly reduce this burden but have slightly lower bioavailability. The disease itself causes notable suffering — cats feel hypermetabolic, anxious, and often hypertensive, causing headache-equivalent discomfort. Achieving stable thyroid levels dramatically improves quality of life: cats typically regain weight, activity, and calm temperament within weeks of effective treatment.